These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 34620070)
21. Comprehensive MRI quantification of the substantia nigra pars compacta in Parkinson's disease. Takahashi H; Watanabe Y; Tanaka H; Mihara M; Mochizuki H; Takahashi K; Yamamoto K; Liu T; Wang Y; Tomiyama N Eur J Radiol; 2018 Dec; 109():48-56. PubMed ID: 30527311 [TBL] [Abstract][Full Text] [Related]
22. Awareness and current knowledge of Parkinson's disease: a neurodegenerative disorder. Khan AU; Akram M; Daniyal M; Zainab R Int J Neurosci; 2019 Jan; 129(1):55-93. PubMed ID: 29883227 [TBL] [Abstract][Full Text] [Related]
24. Tremor amplitude and tremor frequency variability in Parkinson's disease is dependent on activity and synchronisation of central oscillators in basal ganglia. Bartolić A; Pirtosek Z; Rozman J; Ribaric S Med Hypotheses; 2010 Feb; 74(2):362-5. PubMed ID: 19656636 [TBL] [Abstract][Full Text] [Related]
29. Inflammation in Parkinson's disease: an update. Smith PF Curr Opin Investig Drugs; 2008 May; 9(5):478-84. PubMed ID: 18465657 [TBL] [Abstract][Full Text] [Related]
30. Parkinson's disease-related increase of T2*-weighted hypointensity in substantia nigra pars compacta. Langley J; Huddleston DE; Sedlacik J; Boelmans K; Hu XP Mov Disord; 2017 Mar; 32(3):441-449. PubMed ID: 28004859 [TBL] [Abstract][Full Text] [Related]
31. Prospective memory in Parkinson's disease: the role of the motor subtypes. D'Iorio A; Maggi G; Vitale C; Amboni M; Di Meglio D; Trojano L; Santangelo G J Neurol; 2019 Oct; 266(10):2505-2511. PubMed ID: 31256281 [TBL] [Abstract][Full Text] [Related]
32. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores. Atasoy HT; Nuyan O; Tunc T; Yorubulut M; Unal AE; Inan LE Neurol India; 2004 Sep; 52(3):332-7. PubMed ID: 15472421 [TBL] [Abstract][Full Text] [Related]
33. The role of DJ-1 in the pathogenesis of Parkinson's disease. Wang ZQ; Zhou HY; Chen SD Neurosci Bull; 2006 Jul; 22(4):232-4. PubMed ID: 17704838 [TBL] [Abstract][Full Text] [Related]
34. Parkinson's disease: Autoimmunity and neuroinflammation. De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913 [TBL] [Abstract][Full Text] [Related]
35. Bee venom for the treatment of Parkinson's disease: How far is it possible? Awad K; Abushouk AI; AbdelKarim AH; Mohammed M; Negida A; Shalash AS Biomed Pharmacother; 2017 Jul; 91():295-302. PubMed ID: 28477460 [TBL] [Abstract][Full Text] [Related]
36. Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back. Bergman H; Deuschl G Mov Disord; 2002; 17 Suppl 3():S28-40. PubMed ID: 11948753 [TBL] [Abstract][Full Text] [Related]
37. Neuronal oscillations in Parkinson's disease. Witcher M; Moran R; Tatter SB; Laxton AW Front Biosci (Landmark Ed); 2014 Jun; 19(8):1291-9. PubMed ID: 24896351 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA Dysregulation in Parkinson's Disease: A Narrative Review. Nies YH; Mohamad Najib NH; Lim WL; Kamaruzzaman MA; Yahaya MF; Teoh SL Front Neurosci; 2021; 15():660379. PubMed ID: 33994934 [TBL] [Abstract][Full Text] [Related]